OBJECTIVE
The present study evaluated the potential role of soybean lectin's (SBL) anticancer effect in vitro in different cancer cell lines and the therapeutic effectiveness in vivo in Dalton's lymphoma (DL) bearing mice model.
METHODS
The effect of SBL on cell growth and viability was measured